JS-K, a Nitric Oxide Prodrug, Has Enhanced Cytotoxicity in Colon Cancer Cells with Knockdown of Thioredoxin Reductase 1

Open Access

Peer-reviewed

Research Article

Kornelia Edes,

Affiliation Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States of America
⨯
Pamela Cassidy,

Affiliations Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States of America, Department of Dermatology, University of Utah, Salt Lake City, Utah, United States of America, Department of Medicinal Chemistry, University of Utah, Salt Lake City, Utah, United States of America
⨯
Paul J. Shami,

Affiliation Department of Medicinal Oncology, University of Utah, Salt Lake City, Utah, United States of America
⨯
Philip J. Moos

* E-mail: philip.moos@utah.edu

Affiliation Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah, United States of America
⨯

Reader Comments (0)

Oxidation-reduction reactions
Is the Subject Area "Oxidation-reduction reactions" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Cytotoxicity
Is the Subject Area "Cytotoxicity" applicable to this article?

Thanks for your feedback.
Nitric oxide
Is the Subject Area "Nitric oxide" applicable to this article?

Thanks for your feedback.
MTT assay
Is the Subject Area "MTT assay" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.